Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Precision Medicine Market

Published Date : Mar 2024

The global precision medicine market is estimated to be valued at USD 92.31 Bn in 2024 and is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031). Precision medicine is an emerging approach for disease treatment and prevention that takes into ac... View more

Coherent Market Insights Veterinary Vaccines Market

Published Date : Mar 2024

Global veterinary vaccines market is estimated to be valued at USD 9.70 Bn in 2024 and is expected to exhibit a CAGR of 7.6% during the forecast period (2024-2031). Veterinary vaccines are biological preparations administered to animals in order to stimulate the immun... View more

Coherent Market Insights Fibromyalgia Treatment Market

Published Date : Mar 2024

Global fibromyalgia treatment market is estimated to be valued at USD 3.07 BN in 2024 and is expected to exhibit a CAGR of 3.3% during the forecast period (2024-2031). Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, l... View more

Coherent Market Insights Viscosupplementation Market

Published Date : Mar 2024

Global viscosupplementation market is estimated to be valued at USD 3.84 Bn in 2024 and is expected to exhibit a CAGR of 7.8% during the forecast period (2024-2031). Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It inv... View more

Coherent Market Insights Pd 1 And Pdl 1 Inhibitors Market

Published Date : Mar 2024

Global PD-1 and PD-L1 inhibitor market is estimated to be valued at USD 52.51 Bn in 2024 and is expected to exhibit a CAGR of 18.3% during the forecast period (2024-2031). PD-1 and PD-L1 inhibitors are immune checkpoint inhibitors that have shown promising results in ... View more

Coherent Market Insights Lenalidomide Drug Market

Published Date : Mar 2024

The Lenalidomide Drug Market is estimated to be valued at USD 13.21 Bn in 2024 and is expected to reach USD 20.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Lenalidomideis an immunomodula... View more

Coherent Market Insights Cosentyx Drug Market

Published Date : Mar 2024

Global cosentyx drug market is estimated to be valued at USD 5.32 Bn in 2024, and is expected to reach USD 8.74 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031. Cosentyx (secukinumab) is a huma... View more

Coherent Market Insights Sevoflurane Market

Published Date : Mar 2024

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether that is used as an inhalational anesthetic for general anesthesia induction and maintenance. It is the fastest-acting volatile anesthetic after desflurane. ... View more

Coherent Market Insights Medical Second Opinion Market

Published Date : Mar 2024

The medical second opinion market is estimated to be valued at USD 7.12 Bn in 2024 and is expected to reach USD 20.45 Bn by 2031, growing at a compound annual growth rate (CAGR) of 16.3% from 2024 to 2031. The global medical second... View more

Coherent Market Insights Global Non Opioid Pain Treatment Market

Published Date : Mar 2024

Global non opioid pain treatment market is estimated to be valued at USD 43.67 billion in 2024 and is expected to reach USD 75.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031. Rising pr... View more

Coherent Market Insights Bovine Mastitis Market

Published Date : Mar 2024

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's... View more

Coherent Market Insights Eosinophilic Esophagitis Market

Published Date : Mar 2024

Eosinophilic esophagitis is a chronic condition which is treated with the help of steroids and acid suppressants such as proton pump inhibitors. Steroids help control the inflammation. Topical steroids are administered as a inhaler or as a liquid. Oral steroids may be... View more

Coherent Market Insights Spinal Muscular Atrophy Market

Published Date : Mar 2024

Spinal muscular atrophy (SMA) is a genetic disease that affects the peripheral nervous system, central nervous system, and voluntary muscle movement (skeletal muscle). SMA is muscular since it primarily affects muscles, which do not receive impulses fro... View more

Coherent Market Insights Urinary Tract Infection Treatment Market

Published Date : Mar 2024

A urinary tract infection (UTI) is an infection in any part of the urinary system. Women are at greater risk of developing a urinary tract infection compared to men. Urinary tract infections (UTIs) are usually caused by bacteria from poo entering the urinary tract. An... View more

Coherent Market Insights Intravenous Solutions Market

Published Date : Mar 2024

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Ther... View more

Coherent Market Insights Generic Sterile Injectable Market

Published Date : Mar 2024

The generic sterile injectable are U.S. FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counter... View more

Coherent Market Insights Global Pharmaceutical Intermediates Market

Published Date : Mar 2024

The pharmaceutical intermediates market is estimated to be valued at USD 43.67 billion in 2024 and is expected to reach USD 75.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031. The pharm... View more

Coherent Market Insights Global Physiotherapy Services Market

Published Date : Mar 2024

Physiotherapy services market is estimated to be valued at USD 55.23 Bn in 2024 and is expected to reach USD 79.34 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031. Physiotherapy is a crucial pa... View more

Coherent Market Insights Severs Disease Treatment Market

Published Date : Mar 2024

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 1.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031. Sever's disease, ... View more

Coherent Market Insights Medicinal Cannabis Market

Published Date : Mar 2024

The global medicinal cannabis market size is valued at USD 19.44 BN in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031. Medicinal cannabis, also known as medical marijuana, refers to using the whole unprocessed marijua... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.